Lundbeck
HLUN-B.CO
#2582
Rank
NZ$9.52 B
Marketcap
$9.99
Share price
-0.98%
Change (1 day)
32.41%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$10.48 Billion

According to Lundbeck 's latest financial reports the company's total assets are NZ$10.48 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lundbeck - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$8.76 B3.13%
2022-12-31NZ$8.49 B9.98%
2021-12-31NZ$7.72 B-6.42%
2020-12-31NZ$8.25 B-2.77%
2019-12-31NZ$8.48 B61.52%
2018-12-31NZ$5.25 B17.2%
2017-12-31NZ$4.48 B8.56%
2016-12-31NZ$4.13 B-9.53%
2015-12-31NZ$4.56 B-14.56%
2014-12-31NZ$5.34 B0.3%
2013-12-31NZ$5.32 B14.64%
2012-12-31NZ$4.64 B1.4%
2011-12-31NZ$4.58 B10.05%
2010-12-31NZ$4.16 B-8.31%
2009-12-31NZ$4.54 B12.07%
2008-12-31NZ$4.05 B28.71%
2007-12-31NZ$3.14 B7.58%
2006-12-31NZ$2.92 B8.68%
2005-12-31NZ$2.69 B-8.26%
2004-12-31NZ$2.93 B